Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Immuno-oncology: the leading companies in oncolytic viral proteins revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
Immuno-oncology: the leading companies in oncolytic adenovirus vectors revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Immuno-oncology: the leading companies in neoepitope prediction revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Immuno-oncology: the leading companies in oncolytic viruses revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Immuno-oncology: the leading companies in cancer immunotherapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Immuno-oncology: the leading companies in immunotherapy radiotherapy combination revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by by the evolution of treatment...
Innovation in immuno-oncology: Leading companies in CAR-T cell-based compositions
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Innovation in immuno-oncology: Leading companies in monoclonal antibody conjugates for cancer treatment
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Innovation in immuno-oncology: Leading companies in cancer radiotherapy
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Innovation in immuno-oncology: Leading companies in cytotoxic T-cell based cancer immunotherapy
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Innovation in immuno-oncology: Leading companies in tumour antibody serum compositions
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Innovation in immuno-oncology: Leading companies in in-vitro T-cell activation
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Innovation in immuno-oncology: Leading companies in cancer monoclonal antibody therapy
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms...
Innovation in immuno-oncology: Leading companies in gene therapy delivery using viral vectors
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Innovation in immuno-oncology: Leading companies in antibody drug conjugates (ADC) cancer therapy
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Innovation in immuno-oncology: Leading companies in cancer chimeric antigen receptor (CAR) T-cell therapy
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Innovation in immuno-oncology: Leading companies in anti-tumour antibodies
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Innovation in immuno-oncology: Leading companies in bridged diaryl derivatives-based cancer drug compositions
The pharmaceuticalindustry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, the...
Innovation in immuno-oncology: Leading companies in alpha-cinnamide compositions for cancer
The pharmaceuticalindustry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms and...